Rapid delivery of toxicological material
Drug Target Review
SEPTEMBER 10, 2024
Rapid delivery of IND-enabling Tox testing is crucial for a timely IND submission Advanced technologies enabling increasingly rapid timelines from vector construction to good manufacturing practice (GMP) manufacture brings the prospect of ever shorter timelines to IND readiness. FDA no longer has to require animal testing for new drugs.
64 
Let's personalize your content